A detailed history of Denali Advisors LLC transactions in Embecta Corp. stock. As of the latest transaction made, Denali Advisors LLC holds 60,300 shares of EMBC stock, worth $1.12 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
60,300
Previous 60,300 -0.0%
Holding current value
$1.12 Million
Previous $753,000 12.88%
% of portfolio
0.09%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$10.13 - $14.6 $96,235 - $138,700
9,500 Added 18.7%
60,300 $753,000
Q1 2024

Apr 19, 2024

SELL
$12.35 - $19.33 $140,160 - $219,376
-11,349 Reduced 18.26%
50,800 $674,000
Q4 2023

Jan 19, 2024

SELL
$12.87 - $19.09 $387,387 - $574,609
-30,100 Reduced 32.63%
62,149 $1.18 Million
Q3 2023

Oct 19, 2023

BUY
$15.0 - $22.17 $910,845 - $1.35 Million
60,723 Added 192.61%
92,249 $1.39 Million
Q2 2023

Jul 18, 2023

BUY
$21.6 - $30.69 $680,961 - $967,532
31,526 New
31,526 $680,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.08B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.